FDA is proposing to classify posterior cervical screw systems into Class II (special controls) and to continue to require premarket notification for the devices.
A posterior cervical screw system is a prescription device used to provide immobilization and stabilization in the cervical spine as an adjunct to spinal fusion. The term “posterior cervical screw system” is used to distinguish these devices from currently-classified pedicle screws cleared for use in other spinal regions.
FDA’s panel supports this recommendation because special controls plus general controls would provide reasonable assurance of the safety and effectiveness of the device. The risks to health for this device type are known, and can be adequately mitigated by special controls (e.g., mechanical testing, biocompatibility and labeling).
FDA will accept comments through June 8, 2016.
Source: FDA, federalregister.gov
Click here to review the regulatory history of the posterior cervical screw system.
FDA is proposing to classify posterior cervical screw systems into Class II (special controls) and to continue to require premarket notification for the devices.
A posterior cervical screw system is a prescription device used to provide immobilization and stabilization in the cervical spine as an adjunct to spinal fusion. The term “posterior...
FDA is proposing to classify posterior cervical screw systems into Class II (special controls) and to continue to require premarket notification for the devices.
A posterior cervical screw system is a prescription device used to provide immobilization and stabilization in the cervical spine as an adjunct to spinal fusion. The term “posterior cervical screw system” is used to distinguish these devices from currently-classified pedicle screws cleared for use in other spinal regions.
FDA’s panel supports this recommendation because special controls plus general controls would provide reasonable assurance of the safety and effectiveness of the device. The risks to health for this device type are known, and can be adequately mitigated by special controls (e.g., mechanical testing, biocompatibility and labeling).
FDA will accept comments through June 8, 2016.
Source: FDA, federalregister.gov
Click here to review the regulatory history of the posterior cervical screw system.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.